|
ILMN | Illumina, Inc. |
| Laboratory Analytical Instruments |
| Book value per $ invested | $ 0.12 |
| Leverage | 61.45% |
| Market Cap | $ 19.1B |
| PE | 27.15 |
| Dividend Yield | 0.00% |
| Profit | $ 702.0m |
| Margin | 15.73% |
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.